BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30924900)

  • 41. Investigating a Genetic Link Between Alzheimer's Disease and CADASIL-Related Cerebral Small Vessel Disease.
    Dunn PJ; Lea RA; Maksemous N; Smith RA; Sutherland HG; Haupt LM; Griffiths LR
    Mol Neurobiol; 2022 Dec; 59(12):7293-7302. PubMed ID: 36175824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
    Cuyvers E; De Roeck A; Van den Bossche T; Van Cauwenberghe C; Bettens K; Vermeulen S; Mattheijssens M; Peeters K; Engelborghs S; Vandenbulcke M; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Sleegers K
    Lancet Neurol; 2015 Aug; 14(8):814-822. PubMed ID: 26141617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TYROBP genetic variants in early-onset Alzheimer's disease.
    Pottier C; Ravenscroft TA; Brown PH; Finch NA; Baker M; Parsons M; Asmann YW; Ren Y; Christopher E; Levitch D; van Blitterswijk M; Cruchaga C; Campion D; Nicolas G; Richard AC; Guerreiro R; Bras JT; Zuchner S; Gonzalez MA; Bu G; Younkin S; Knopman DS; Josephs KA; Parisi JE; Petersen RC; Ertekin-Taner N; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
    Neurobiol Aging; 2016 Dec; 48():222.e9-222.e15. PubMed ID: 27658901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Early-Onset Alzheimer's Disease Whole-Genome Sequencing Project: Study design and methodology.
    Ray NR; Ayodele T; Jean-Francois M; Baez P; Fernandez V; Bradley J; Crane PK; Dalgard CL; Kuzma A; Nicaretta H; Sims R; Williams J; Cuccaro ML; Pericak-Vance MA; Mayeux R; Wang LS; Schellenberg GD; Cruchaga C; Beecham GW; Reitz C
    Alzheimers Dement; 2023 Sep; 19(9):4187-4195. PubMed ID: 37390458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.
    Wingo TS; Cutler DJ; Wingo AP; Le NA; Rabinovici GD; Miller BL; Lah JJ; Levey AI
    JAMA Neurol; 2019 Jul; 76(7):809-817. PubMed ID: 31135820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer's disease in Caribbean Hispanics.
    Horimoto ARVR; Xue D; Thornton TA; Blue EE
    Alzheimers Res Ther; 2021 Jul; 13(1):122. PubMed ID: 34217363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease.
    Guerreiro RJ; Lohmann E; Kinsella E; Brás JM; Luu N; Gurunlian N; Dursun B; Bilgic B; Santana I; Hanagasi H; Gurvit H; Gibbs JR; Oliveira C; Emre M; Singleton A
    Neurobiol Aging; 2012 May; 33(5):1008.e17-23. PubMed ID: 22153900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2.
    Karsak M; Glebov K; Scheffold M; Bajaj T; Kawalia A; Karaca I; Rading S; Kornhuber J; Peters O; Diez-Fairen M; Frölich L; Hüll M; Wiltfang J; Scherer M; Riedel-Heller S; Schneider A; Heneka MT; Fliessbach K; Sharaf A; Thiele H; Lennarz M; Jessen F; Maier W; Kubisch C; Ignatova Z; Nürnberg P; Pastor P; Walter J; Ramirez A
    Hum Mutat; 2020 Jan; 41(1):169-181. PubMed ID: 31464095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline.
    Del-Aguila JL; Fernández MV; Schindler S; Ibanez L; Deming Y; Ma S; Saef B; Black K; Budde J; Norton J; Chasse R; ; Harari O; Goate A; Xiong C; Morris JC; Cruchaga C
    J Alzheimers Dis; 2018; 62(2):745-756. PubMed ID: 29480181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia.
    Mori Y; Yoshino Y; Ochi S; Yamazaki K; Kawabe K; Abe M; Kitano T; Ozaki Y; Yoshida T; Numata S; Mori T; Iga J; Kuroda N; Ohmori T; Ueno S
    PLoS One; 2015; 10(9):e0136835. PubMed ID: 26332043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. African ancestry GWAS of dementia in a large military cohort identifies significant risk loci.
    Sherva R; Zhang R; Sahelijo N; Jun G; Anglin T; Chanfreau C; Cho K; Fonda JR; Gaziano JM; Harrington KM; Ho YL; Kremen WS; Litkowski E; Lynch J; Neale Z; Roussos P; Marra D; Mez J; Miller MW; Salat DH; Tsuang D; Wolf E; Zeng Q; Panizzon MS; Merritt VC; Farrer LA; Hauger RL; Logue MW
    Mol Psychiatry; 2023 Mar; 28(3):1293-1302. PubMed ID: 36543923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.
    Luis EO; Ortega-Cubero S; Lamet I; Razquin C; Cruchaga C; Benitez BA; Lorenzo E; Irigoyen J; ; Pastor MA; Pastor P
    Neurobiol Aging; 2014 Dec; 35(12):2681-2690. PubMed ID: 25027412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement.
    Guerreiro RJ; Lohmann E; Brás JM; Gibbs JR; Rohrer JD; Gurunlian N; Dursun B; Bilgic B; Hanagasi H; Gurvit H; Emre M; Singleton A; Hardy J
    JAMA Neurol; 2013 Jan; 70(1):78-84. PubMed ID: 23318515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetics of Alzheimer's disease.
    Chouraki V; Seshadri S
    Adv Genet; 2014; 87():245-94. PubMed ID: 25311924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computational saturation mutagenesis to explore the effect of pathogenic mutations on extra-cellular domains of TREM2 associated with Alzheimer's and Nasu-Hakola disease.
    Swain PS; Panda S; Pati S; Dehury B
    J Mol Model; 2023 Nov; 29(11):360. PubMed ID: 37924367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alternative Splicing Regulation of Low-Frequency Genetic Variants in Exon 2 of
    Han S; Na Y; Koh I; Nho K; Lee Y
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576031
    [No Abstract]   [Full Text] [Related]  

  • 58. NOTCH3 variants and risk of ischemic stroke.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Verbeeck C; Serie DJ; Rayaprolu S; Rich SS; Nalls MA; Singleton A; Guerreiro R; Kinsella E; Wszolek ZK; Brott TG; Brown RD; Worrall BB; Meschia JF
    PLoS One; 2013; 8(9):e75035. PubMed ID: 24086431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel and Recurring NOTCH3 Mutations in Two Chinese Patients with CADASIL.
    Chen X; Deng S; Xu H; Hou D; Hu P; Yang Y; Wen J; Deng H; Yuan L
    Neurodegener Dis; 2019; 19(1):35-42. PubMed ID: 31212292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of GSK3B with Alzheimer disease and frontotemporal dementia.
    Schaffer BA; Bertram L; Miller BL; Mullin K; Weintraub S; Johnson N; Bigio EH; Mesulam M; Wiedau-Pazos M; Jackson GR; Cummings JL; Cantor RM; Levey AI; Tanzi RE; Geschwind DH
    Arch Neurol; 2008 Oct; 65(10):1368-74. PubMed ID: 18852354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.